» Articles » PMID: 17603475

An Improved Zinc-finger Nuclease Architecture for Highly Specific Genome Editing

Overview
Journal Nat Biotechnol
Specialty Biotechnology
Date 2007 Jul 3
PMID 17603475
Citations 487
Authors
Affiliations
Soon will be listed here.
Abstract

Genome editing driven by zinc-finger nucleases (ZFNs) yields high gene-modification efficiencies (>10%) by introducing a recombinogenic double-strand break into the targeted gene. The cleavage event is induced using two custom-designed ZFNs that heterodimerize upon binding DNA to form a catalytically active nuclease complex. Using the current ZFN architecture, however, cleavage-competent homodimers may also form that can limit safety or efficacy via off-target cleavage. Here we develop an improved ZFN architecture that eliminates this problem. Using structure-based design, we engineer two variant ZFNs that efficiently cleave DNA only when paired as a heterodimer. These ZFNs modify a native endogenous locus as efficiently as the parental architecture, but with a >40-fold reduction in homodimer function and much lower levels of genome-wide cleavage. This architecture provides a general means for improving the specificity of ZFNs as gene modification reagents.

Citing Articles

Applications of Gene Editing and Nanotechnology in Stem Cell-Based Therapies for Human Diseases.

Bolideei M, Barzigar R, Gahrouei R, Mohebbi E, Haider K, Paul S Stem Cell Rev Rep. 2025; .

PMID: 40014250 DOI: 10.1007/s12015-025-10857-0.


Advancements in genome editing tools for genetic studies and crop improvement.

Ahmadikhah A, Zarabizadeh H, Nayeri S, Abbasi M Front Plant Sci. 2025; 15:1370675.

PMID: 39963359 PMC: 11830681. DOI: 10.3389/fpls.2024.1370675.


Mitochondrial base editing: from principle, optimization to application.

Tang J, Du K Cell Biosci. 2025; 15(1):9.

PMID: 39856740 PMC: 11762502. DOI: 10.1186/s13578-025-01351-8.


Groundbreaking Technologies and the Biocontrol of Fungal Vascular Plant Pathogens.

Gomez-Lama Cabanas C, Mercado-Blanco J J Fungi (Basel). 2025; 11(1).

PMID: 39852495 PMC: 11766565. DOI: 10.3390/jof11010077.


Current Knowledge on CRISPR Strategies Against Antimicrobial-Resistant Bacteria.

de la Fuente Tagarro C, Martin-Gonzalez D, De Lucas A, Bordel S, Santos-Beneit F Antibiotics (Basel). 2025; 13(12.

PMID: 39766530 PMC: 11672446. DOI: 10.3390/antibiotics13121141.